Clinical Trial Update: Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing Gemcitabine/Cisplatin versus S-1/Cisplatin in advanced biliary tract cancers has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Gyeongsang National University Hospital | Conditions: Metastatic Biliary Tract Cancer, Locally Advanced Biliary Tract Cancer | Phase 2 | Status: TERMINATED